Abstract
The kallikrein related peptidase gene family (KLKs) comprises 15 genes located between 19q13.3-13.4. KLKs have chymotrypsin and/or trypsin like activity, but the tissue/organ expression profile of each KLK varies considerably. Thus, the role of KLKs in human biology is also very diverse, and the deregulation of their function results in a wide-range of diseases. Here, we have cataloged the transcript (variants and fusions) and genetic (single nucleotide polymorphisms, small insertions/deletions, copy number variations (CNVs), and short tandem repeats) diversity at the KLK locus, providing a data set for researchers to explore the mechanisms through which KLK function may be deregulated. We reveal that the KLK locus hosts 85 fusion transcripts, and 80 variant transcripts. Interestingly, some fusion transcripts comprise up to 6 KLK genes. Our analysis of genetic variations of 2504 individuals from the 1000 Genome Project indicated that the KLK locus is rich in genetic diversity, with some fusion transcripts harboring over 1000 single nucleotide variations. We also found evidence from the literature linking 2387 KLK genetic variants with many types of diseases. Finally, genotyping data from the 131 KLK genetic variants in the NCI-60 cancer cell lines is provided as a resource for the cancer and KLK field.
Acknowledgments
J.A Clements is an NHMRC Principal Research Fellow, and J. Batra is an NHMRC Career Development Fellow. This study was supported by NHMRC project grant APP1050742.
References
Alley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., Mayo, J.G., Shoemaker, R.H., and Boyd, M.R. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589–601.Suche in Google Scholar
Batra, J., O’Mara, T., Patnala, R., Lose, F., and Clements, J.A. (2012). Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases. Biol. Chem. 393, 1365–1390.10.1515/hsz-2012-0211Suche in Google Scholar
Bayani, J., Marrano, P., Graham, C., Zheng, Y., Li, L., Katsaros, D., Lassus, H., Butzow, R., Squire, J.A., and Diamandis, E.P. (2011). Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. Mol. Oncol. 5, 48–60.10.1016/j.molonc.2010.08.002Suche in Google Scholar
Chelala, C., Khan, A., and Lemoine, N.R. (2009). SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms. Bioinformatics 25, 655–661.10.1093/bioinformatics/btn653Suche in Google Scholar
Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., Moss, P., Paeper, B., and Wang, K. (2000). Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257, 119–130.10.1016/S0378-1119(00)00382-6Suche in Google Scholar
Genomes Project, C., Abecasis, G.R., Altshuler, D., Auton, A., Brooks, L.D., Durbin, R.M., Gibbs, R.A., Hurles, M.E., and McVean, G.A. (2010). A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073.10.1038/nature09534Suche in Google Scholar PubMed PubMed Central
Girgis, A.H., Bui, A., White, N.M., and Yousef, G.M. (2012). Integrated genomic characterization of the kallikrein gene locus in cancer. Anticancer Res. 32, 957–963.Suche in Google Scholar
Gymrek, M., Golan, D., Rosset, S., and Erlich, Y. (2012). lobSTR: A short tandem repeat profiler for personal genomes. Genome Res. 22, 1154–1162.10.1007/978-3-642-29627-7_7Suche in Google Scholar
Harvey, T.J., Hooper, J.D., Myers, S.A., Stephenson, S.A., Ashworth, L.K., and Clements, J.A. (2000). Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275, 37397–37406.10.1074/jbc.M004525200Suche in Google Scholar PubMed
Iyer, M.K., Niknafs, Y.S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T.R., Prensner, J.R., Evans, J.R., Zhao, S., et al. (2015). The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199–208.10.1038/ng.3192Suche in Google Scholar PubMed PubMed Central
Koumandou, V.L. and Scorilas, A. (2013). Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. PLoS One 8, e68074.10.1371/journal.pone.0068074Suche in Google Scholar PubMed PubMed Central
Kurlender, L., Borgono, C., Michael, I.P., Obiezu, C., Elliott, M.B., Yousef, G.M., and Diamandis, E.P. (2005). A survey of alternative transcripts of human tissue kallikrein genes. Biochim. Biophys. Acta 1755, 1–14.10.1016/j.bbcan.2005.02.001Suche in Google Scholar PubMed
Lai, J., Lehman, M.L., Dinger, M.E., Hendy, S.C., Mercer, T.R., Seim, I., Lawrence, M.G., Mattick, J.S., Clements, J.A., and Nelson, C.C. (2010). A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells. RNA 16, 1156–1166.10.1261/rna.2019810Suche in Google Scholar PubMed PubMed Central
Lawrence, M.G., Lai, J., and Clements, J.A. (2010). Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr. Rev. 31, 407–446.10.1210/er.2009-0034Suche in Google Scholar PubMed
Lindahl, P., Sall, T., Bjartell, A., Johansson, A.M., Lilja, H., and Hallden, C. (2013). Copy number variants in the kallikrein gene cluster. PLoS One 8, e69097.10.1371/journal.pone.0069097Suche in Google Scholar PubMed PubMed Central
Margulies, M., Egholm, M., Altman, W.E., Attiya, S., Bader, J.S., Bemben, L.A., Berka, J., Braverman, M.S., Chen, Y.J., Chen, Z., et al. (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376–380.10.1038/nature03959Suche in Google Scholar PubMed PubMed Central
Parikh, H., Deng, Z., Yeager, M., Boland, J., Matthews, C., Jia, J., Collins, I., White, A., Burdett, L., Hutchinson, A., et al. (2010). A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. Hum. Genet. 127, 91–99.10.1007/s00439-009-0751-5Suche in Google Scholar PubMed PubMed Central
Parra, G., Reymond, A., Dabbouseh, N., Dermitzakis, E.T., Castelo, R., Thomson, T.M., Antonarakis, S.E., and Guigo, R. (2006). Tandem chimerism as a means to increase protein complexity in the human genome. Genome. Res. 16, 37–44.10.1101/gr.4145906Suche in Google Scholar PubMed PubMed Central
Prassas, I., Eissa, A., Poda, G., and Diamandis, E.P. (2015). Unleashing the therapeutic potential of human kallikrein-related serine proteases. Nat. Rev. Drug Discov. 14, 183–202.10.1038/nrd4534Suche in Google Scholar PubMed
Scorilas, A. and Mavridis, K. (2014). Predictions for the future of kallikrein-related peptidases in molecular diagnostics. Expert Rev. Mol. Diagn. 14, 713–722.10.1586/14737159.2014.928207Suche in Google Scholar PubMed
Shankavaram, U.T., Varma, S., Kane, D., Sunshine, M., Chary, K.K., Reinhold, W.C., Pommier, Y., and Weinstein, J.N. (2009). CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10, 277.10.1186/1471-2164-10-277Suche in Google Scholar PubMed PubMed Central
Sukumar, N., Scott, E., Dimitromanolakis, A., Misiak, A., Prassas, I., Diamandis, E.P., and Konvalinka, A. (2014). Mining for single nucleotide variants (SNVs) at the kallikrein locus with predicted functional consequences. Biol. Chem. 395, 1037–1050.10.1515/hsz-2014-0136Suche in Google Scholar PubMed
van Dijk, E.L., Auger, H., Jaszczyszyn, Y., and Thermes, C. (2014). Ten years of next-generation sequencing technology. Trends Genet. 30, 418–426.10.1016/j.tig.2014.07.001Suche in Google Scholar PubMed
Yousef, G.M., Luo, L.Y., and Diamandis, E.P. (1999). Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4. Anticancer Res 19, 2843–2852.Suche in Google Scholar
Supplemental Material:
The online version of this article (DOI: 10.1515/hsz-2016-0161) offers supplementary material, available to authorized users.
©2016 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Guest Editorial
- Highlight: remodelling the KLK landscape down under
- HIGHLIGHT: 6TH INTERNATIONAL SYMPOSIUM ON KALLIKREINS AND KALLIKREIN-RELATED PEPTIDASES
- Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
- Mechanistic insight from murine models of Netherton syndrome
- Development of molecules stimulating the activity of KLK3 – an update
- Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
- Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10
- Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
- Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis
- A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene
- Therapeutic modulation of tissue kallikrein expression
- In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B
- A computational analysis of the genetic and transcript diversity at the kallikrein locus
- Reviews
- Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome
- The power, pitfalls and potential of the nanodisc system for NMR-based studies
- Research Articles/Short Communications
- Cell Biology and Signaling
- Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1β and 5-azacytidine
Artikel in diesem Heft
- Frontmatter
- Guest Editorial
- Highlight: remodelling the KLK landscape down under
- HIGHLIGHT: 6TH INTERNATIONAL SYMPOSIUM ON KALLIKREINS AND KALLIKREIN-RELATED PEPTIDASES
- Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
- Mechanistic insight from murine models of Netherton syndrome
- Development of molecules stimulating the activity of KLK3 – an update
- Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
- Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10
- Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
- Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis
- A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene
- Therapeutic modulation of tissue kallikrein expression
- In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B
- A computational analysis of the genetic and transcript diversity at the kallikrein locus
- Reviews
- Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome
- The power, pitfalls and potential of the nanodisc system for NMR-based studies
- Research Articles/Short Communications
- Cell Biology and Signaling
- Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1β and 5-azacytidine